𝔖 Bobbio Scriptorium
✦   LIBER   ✦

W1223 Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn's Disease

✍ Scribed by Nichita, Cristina; Stelle, Marc; Vavricka, Stephan R.; El-Wafa, Ali Abdou; De Saussure, Philippe; Straumann, Alex; Rogler, Gerhard; Michetti, Pierre F.

Book ID
122675166
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
51 KB
Volume
136
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab safety in global clinical tri
Adalimumab safety in global clinical trials of patients with Crohn's disease
✍ Jean-FrΓ©dΓ©ric Colombel; William J. Sandborn; Remo Panaccione; Anne M. Robinson; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 2 views

Background: Adalimumab, a fully human anti-tumor necrosis factor (anti-TNF) monoclonal antibody, is approved for the treatment of Crohn's disease (CD) in adults. We evaluated the overall safety profile of adalimumab in global clinical trials in patients with CD. Patients who participated in these tr